HelouMed: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
HelouMed
Largest movements
- Deferred charges and accrued income +€65,193
up €65,193 (+34.6%), from €188,398 to €253,591
- Cash +€62,894
up €62,894 (+58.0%), from €108,427 to €171,321
mainly Other debts (+€492,916) and Net result for the year (+€464,382)
- Receivables within one year -€24,095
down €24,095 (-32.9%), from €73,269 to €49,174
of which Other amounts receivable: -€23,575
- Tangible fixed assets -€21,302
down €21,302 (-28.5%), from €74,846 to €53,544
of which Furniture and vehicles: -€18,487
- Other debts +€492,916
up €492,916 (+397,001%), from €124 to €493,040
- Profit (loss) carried forward -€421,217
down €421,217 (-100%), from €421,217 to €0
- Trade debts +€13,775
up €13,775 (+860%), from €1,602 to €15,377
- Gross operating margin +€69,036
up €69,036 (+12.2%), from €567,078 to €636,114
- Taxes +€15,810
up €15,810 (+11.7%), from €135,315 to €151,125
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €447,940 | €530,630 | +€82,690 | +18.5% |
| Fixed assets | 21/28 | €77,346 | €56,044 | -€21,302 | -27.5% |
| Tangible fixed assets | 22/27 | €74,846 | €53,544 | -€21,302 | -28.5% |
| Plant, machinery and equipment | 23 | €1,904 | €1,157 | -€747 | -39.2% |
| Furniture and vehicles | 24 | €60,265 | €41,778 | -€18,487 | -30.7% |
| Other tangible fixed assets | 26 | €12,677 | €10,609 | -€2,068 | -16.3% |
| Financial fixed assets | 28 | €2,500 | €2,500 | = | 0.0% |
| Current assets | 29/58 | €370,594 | €474,585 | +€103,992 | +28.1% |
| Amounts receivable after more than one year | 29 | €500 | €500 | = | 0.0% |
| Other amounts receivable | 291 | €500 | €500 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €73,269 | €49,174 | -€24,095 | -32.9% |
| Trade receivables | 40 | €520 | €0 | -€520 | -100% |
| Other amounts receivable | 41 | €72,749 | €49,174 | -€23,575 | -32.4% |
| Cash at bank and in hand | 54/58 | €108,427 | €171,321 | +€62,894 | +58.0% |
| Deferred charges and accrued income | 490/1 | €188,398 | €253,591 | +€65,193 | +34.6% |
| Total equity and liabilities | 10/49 | €447,940 | €530,630 | +€82,690 | +18.5% |
| Equity | 10/15 | €441,677 | €20,460 | -€421,217 | -95.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €421,217 | €0 | -€421,217 | -100% |
| Amounts payable | 17/49 | €6,263 | €510,170 | +€503,907 | +8,046% |
| Amounts payable within one year | 42/48 | €4,448 | €510,170 | +€505,722 | +11,370% |
| Financial debts | 43 | €1,096 | €126 | -€970 | -88.5% |
| Credit institutions | 430/8 | €1,096 | €126 | -€970 | -88.5% |
| Trade debts | 44 | €1,602 | €15,377 | +€13,775 | +860% |
| Suppliers | 440/4 | €1,602 | €15,377 | +€13,775 | +860% |
| Taxes, remuneration and social security | 45 | €1,626 | €1,626 | = | 0.0% |
| Taxes | 450/3 | €1,626 | €1,626 | = | 0.0% |
| Other amounts payable | 47/48 | €124 | €493,040 | +€492,916 | +397,001% |
| Accrued charges and deferred income | 492/3 | €1,815 | €0 | -€1,815 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,993 | €21,302 | +€309 | +1.5% |
| Other operating charges | 640/8 | €711 | €855 | +€144 | +20.3% |
| Gross operating margin | 9900 | €567,078 | €636,114 | +€69,036 | +12.2% |
| Operating profit (loss) | 9901 | €545,374 | €613,958 | +€68,584 | +12.6% |
| Financial income | 75/76B | €3,580 | €1,810 | -€1,770 | -49.4% |
| Recurring financial income | 75 | €3,580 | €1,810 | -€1,770 | -49.4% |
| Financial charges | 65/66B | €86 | €262 | +€175 | +203% |
| Recurring financial charges | 65 | €86 | €262 | +€175 | +203% |
| Profit (loss) for the period before taxes | 9903 | €548,868 | €615,507 | +€66,638 | +12.1% |
| Income taxes | 67/77 | €135,315 | €151,125 | +€15,810 | +11.7% |
| Profit (loss) for the period | 9904 | €413,554 | €464,382 | +€50,828 | +12.3% |
| Profit (loss) for the period to be appropriated | 9905 | €413,554 | €464,382 | +€50,828 | +12.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.